Drug intelligence / Profile preview

TMN-1

Development stage: Unknown
Administration: Oral

Overview

**TMN-1** is an orally administered traditional Chinese herbal medicine mixture used in Taiwan as a nonhormonal intervention for menopausal hot flashes. It combines the classical multi-herb formulas Chia-Wei-Hsiao-Yao-San, Chih-Po-Ti-Huang-Wan, and Hsiang-Sha-Liu-Chun-Tzu-Tang. Its molecular targets and pharmacologic mechanism have not been established; it was evaluated in a multicenter prospective observational study sponsored by National Taiwan University Hospital for menopausal hot flashes and climacteric symptoms. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00275964))

Beyond the preview

Go deeper on TMN-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMN-1.

Explore the full profile